USMJ - Puration Inc. and Kali-Extracts Inc. Announce THC Extraction Partnership
DALLAS, Texas, Dec. 18, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE --Puration, Inc. (USOTC: PURA) (“PURA”) and Kali, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a THC extraction partnership. The two companies will combine efforts and resources in the extraction of THC for respective products to be produced by the two companies. PURA requires THC extract for its new THCSavor Beverage and KALY plans to produce THC extract for vapes. KALY owns a patented cannabis extraction process which PURA has licensed for specific purposes to include PURA’s primary business, the production of cannabis infused beverages. Together, PURA and KALY plan to contract licensed extraction facilities in Colorado and California to produce THC under KALY’s patented process and supervision. PURA and KALY, through their partnership, expect to optimize economies of scale in the production of high-quality THC extract.
In conjunction with the marketing of PURA’s THC Savor produced under KALY’s patented extraction process, PURA plans to launch a marketing campaign in the spring of 2019 in partnership with the AmeriCanna Cafe launch in Colorado. The AmeriCanna Cafe is a concept restaurant subsidiary founded by North American Cannabis Holdings, Inc. (USOTC: USMJ) and recently spun-off in a sale to Priority Aviation (USOTC: PJET) (name change underway). The AmeriCanna Cafe is being launched in Colorado this spring in a partnership with West Coast Venture Group (OTCQB: WCVC).
To learn more about Puration, Inc., visit www.purationinc.com.
To learn more about Kali-Extracts, Inc., visit www.kali-extracts.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Kali, Inc.
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350